ROS -mediated anticancer response of potent copper(II) drug entities derived from S, O and N, N chelating donor scaffold: Single X-ray crystal diffraction and spectroscopic studies

化学 单斜晶系 结晶学 细胞毒性 三斜晶系 单晶 螯合作用 氧化还原 晶体结构 立体化学 体外 无机化学 生物化学 有机化学
作者
Shariq Yousuf,Farukh Arjmand,Sartaj Tabassum
出处
期刊:Journal of Molecular Structure [Elsevier BV]
卷期号:1262: 132989-132989 被引量:3
标识
DOI:10.1016/j.molstruc.2022.132989
摘要

• The structure of complexes 1 and 2 were thoroughly characterized. • The complexes 1 and 2 were synthesized with an idea of attaining a quick biologically Cu(II)/Cu(I) redox cycle. • The high in vitro cytotoxicity exhibited by five coordinated Cu(II) complex. • Mode of binding of 1 and 2 towards ct-DNA was studied. New Cu(II) anticancer drug entities derived from S, O, and N, N donor chelating scaffolds were synthesized and thoroughly characterized by various spectroscopic and single X-ray diffraction studies. The single X-ray crystal structure of 1 and 2 revealed a monoclinic and triclinic crystal system with space group C 2 / c and P -1, respectively. The biomolecular interaction studies of 1 and 2 with ct-DNA were carried out by employing a battery of biophysical techniques, viz., absorption, emission, circular dichroic, and electrochemical (CV) and corroborative results of these experiments demonstrated avid electrostatic binding via surface groove. The synthesized Cu(II) complexes showed high efficacy as ROS generators involving Cu(II)/Cu(I) redox-active pair as evidenced by cleavage assay in the presence of radical scavengers. The ROS generation in the presence of copper-based complexes is considered one of the most favorable cell death mechanisms for the inhibition of cancers. In vitro anticancer activity of 1 and 2 was, therefore, evaluated against a panel of five human cancer cell lines, namely MCF-7, MDA-MB-231, Hop-62, AW1356, and SiHa, and results of cytotoxicity demonstrated good anticancer response against all tested cancerous strains with GI 50 value <10 µM, except by 1 against MDA-MB-231, Hop-62 and AW1356 cell lines. Interestingly, 2 has displayed considerable cytotoxicity against MCF-7, Hop-62, and SiHa cancer cell lines even better than that of standard drug adriamycin. Furthermore, computational DFT studies validated the high binding efficacy and significant cytotoxicity of complex 2, which could be attributed to high positive charge density over the Cu(II) center. ROS induced DNA damage resulted Cell Death.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
飞云完成签到 ,获得积分10
1秒前
满天星辰独览完成签到 ,获得积分10
1秒前
九天完成签到 ,获得积分10
2秒前
Bin_Liu发布了新的文献求助10
2秒前
feiyang完成签到 ,获得积分10
3秒前
超帅无色发布了新的文献求助10
3秒前
QCB完成签到 ,获得积分10
5秒前
爱笑半雪完成签到,获得积分10
6秒前
CipherSage应助知犯何逆采纳,获得10
7秒前
淡淡月饼完成签到,获得积分10
11秒前
11秒前
超帅无色完成签到,获得积分20
12秒前
snow完成签到 ,获得积分10
13秒前
16秒前
dream完成签到 ,获得积分10
18秒前
唐唐发布了新的文献求助10
18秒前
史克珍香完成签到 ,获得积分10
24秒前
晓风完成签到,获得积分10
27秒前
CR完成签到 ,获得积分10
28秒前
mammer应助超帅无色采纳,获得10
29秒前
科研通AI2S应助科研通管家采纳,获得10
29秒前
所所应助科研通管家采纳,获得10
30秒前
Owen应助科研通管家采纳,获得10
30秒前
30秒前
lilylwy完成签到 ,获得积分0
30秒前
li完成签到 ,获得积分10
30秒前
可爱的函函应助唐唐采纳,获得10
35秒前
小石头完成签到,获得积分10
37秒前
量子星尘发布了新的文献求助10
41秒前
xiaoxiaoxingchen完成签到 ,获得积分10
41秒前
laohu完成签到,获得积分10
42秒前
风格完成签到,获得积分10
42秒前
大橙子发布了新的文献求助150
44秒前
八点必起完成签到,获得积分10
45秒前
sduweiyu完成签到 ,获得积分10
46秒前
hyf完成签到 ,获得积分10
47秒前
aldehyde应助芊芊要发SCI采纳,获得10
48秒前
Twinkle完成签到,获得积分10
50秒前
Eureka完成签到,获得积分10
52秒前
56秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038157
求助须知:如何正确求助?哪些是违规求助? 3575869
关于积分的说明 11373842
捐赠科研通 3305650
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022